These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35348038)

  • 1. The potential association between COVID-19 disease and Guillain-Barré syndrome.
    Ergin Beton O; Ozturk Tan O; Bilen S
    Neurol Res; 2022 Sep; 44(9):855-860. PubMed ID: 35348038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship Between Acute Phase Reactants and Disability in Guillian-Barré Syndrome During the COVID-19 Pandemic.
    Yevgi R
    Arch Med Res; 2022 Feb; 53(2):179-185. PubMed ID: 34690009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome.
    Keddie S; Pakpoor J; Mousele C; Pipis M; Machado PM; Foster M; Record CJ; Keh RYS; Fehmi J; Paterson RW; Bharambe V; Clayton LM; Allen C; Price O; Wall J; Kiss-Csenki A; Rathnasabapathi DP; Geraldes R; Yermakova T; King-Robson J; Zosmer M; Rajakulendran S; Sumaria S; Farmer SF; Nortley R; Marshall CR; Newman EJ; Nirmalananthan N; Kumar G; Pinto AA; Holt J; Lavin TM; Brennan KM; Zandi MS; Jayaseelan DL; Pritchard J; Hadden RDM; Manji H; Willison HJ; Rinaldi S; Carr AS; Lunn MP
    Brain; 2021 Mar; 144(2):682-693. PubMed ID: 33313649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome and COVID-19: A 1-year observational multicenter study.
    Filosto M; Cotti Piccinelli S; Gazzina S; Foresti C; Frigeni B; Servalli MC; Sessa M; Cosentino G; Marchioni E; Ravaglia S; Briani C; Castellani F; Zara G; Bianchi F; Del Carro U; Fazio R; Filippi M; Magni E; Natalini G; Palmerini F; Perotti AM; Bellomo A; Osio M; Nascimbene C; Carpo M; Rasera A; Squintani G; Doneddu PE; Bertasi V; Cotelli MS; Bertolasi L; Fabrizi GM; Ferrari S; Ranieri F; Caprioli F; Grappa E; Manganotti P; Bellavita G; Furlanis G; De Maria G; Leggio U; Poli L; Rasulo F; Latronico N; Nobile-Orazio E; Beghi E; Padovani A; Uncini A
    Eur J Neurol; 2022 Nov; 29(11):3358-3367. PubMed ID: 35837806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19-associated Guillain-Barré syndrome: The early pandemic experience.
    Caress JB; Castoro RJ; Simmons Z; Scelsa SN; Lewis RA; Ahlawat A; Narayanaswami P
    Muscle Nerve; 2020 Oct; 62(4):485-491. PubMed ID: 32678460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up.
    Ahmad L; Businaro P; Regalbuto S; Gastaldi M; Zardini E; Panzeri M; Vegezzi E; Fiamingo G; Colombo E; Ravaglia S
    Medicine (Baltimore); 2022 Jul; 101(30):e29704. PubMed ID: 35905215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Guillain-Barre Syndrome Cases during and Prior to the COVID-19 Pandemic: A Multicentric Study.
    Panicker P; R D; Gafoor AV; R PS; Iype T; Jose J; Stanley A
    J Assoc Physicians India; 2023 Sep; 71(9):69-71. PubMed ID: 38700304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
    Luijten LWG; Leonhard SE; van der Eijk AA; Doets AY; Appeltshauser L; Arends S; Attarian S; Benedetti L; Briani C; Casasnovas C; Castellani F; Dardiotis E; Echaniz-Laguna A; Garssen MPJ; Harbo T; Huizinga R; Humm AM; Jellema K; van der Kooi AJ; Kuitwaard K; Kuntzer T; Kusunoki S; Lascano AM; Martinez-Hernandez E; Rinaldi S; Samijn JPA; Scheidegger O; Tsouni P; Vicino A; Visser LH; Walgaard C; Wang Y; Wirtz PW; Ripellino P; Jacobs BC;
    Brain; 2021 Dec; 144(11):3392-3404. PubMed ID: 34553216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant Guillain-Barre syndrome with COVID-19: a case report.
    Mackenzie N; Lopez-Coronel E; Dau A; Maloof D; Mattar S; Garcia JT; Fontecha B; Lanata CM; Guillen-Burgos HF
    BMC Neurol; 2021 Mar; 21(1):135. PubMed ID: 33757457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of serum inflammatory markers on the prognosis of adult and pediatric patients with Guillain-Barré syndrome.
    Ethemoglu O; Calik M
    Neuropsychiatr Dis Treat; 2018; 14():1255-1260. PubMed ID: 29805261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early predictors of functional disability in Guillain-Barré Syndrome.
    Tunç A
    Acta Neurol Belg; 2019 Dec; 119(4):555-559. PubMed ID: 30963477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy.
    Garnero M; Del Sette M; Assini A; Beronio A; Capello E; Cabona C; Reni L; Serrati C; Bandini F; Granata A; Pesce G; Mancardi GL; Uccelli A; Schenone A; Benedetti L
    J Neurol Sci; 2020 Nov; 418():117114. PubMed ID: 32947089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions.
    Filosto M; Cotti Piccinelli S; Gazzina S; Foresti C; Frigeni B; Servalli MC; Sessa M; Cosentino G; Marchioni E; Ravaglia S; Briani C; Castellani F; Zara G; Bianchi F; Del Carro U; Fazio R; Filippi M; Magni E; Natalini G; Palmerini F; Perotti AM; Bellomo A; Osio M; Scopelliti G; Carpo M; Rasera A; Squintani G; Doneddu PE; Bertasi V; Cotelli MS; Bertolasi L; Fabrizi GM; Ferrari S; Ranieri F; Caprioli F; Grappa E; Broglio L; De Maria G; Leggio U; Poli L; Rasulo F; Latronico N; Nobile-Orazio E; Padovani A; Uncini A
    J Neurol Neurosurg Psychiatry; 2021 Jul; 92(7):751-756. PubMed ID: 33158914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased Incidence of Guillain-Barré Syndrome during the COVID-19 Pandemic: A Retrospective Population-Based Study.
    Hafsteinsdóttir B; Dalemo E; Elíasdóttir Ó; Ólafsson E; Axelsson M
    Neuroepidemiology; 2023; 57(1):1-6. PubMed ID: 36366822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 Associated Guillain-Barré Syndrome: A Report of Nine New Cases and a Review of the Literature.
    Ivan AP; Odajiu I; Popescu BO; Davidescu EI
    Medicina (Kaunas); 2022 Jul; 58(8):. PubMed ID: 35893091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of Cerebrospinal Fluid Total Protein and Serum Neutrophil-to-Lymphocyte Ratio with Clinical Outcomes of Guillain-Barre Syndrome Variants.
    Bano S; Nawaz A; Nasim A; Numan A; Zahid M
    J Coll Physicians Surg Pak; 2024 Feb; 34(2):187-192. PubMed ID: 38342870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zika virus disease-associated Guillain-Barré syndrome-Barranquilla, Colombia 2015-2016.
    Salinas JL; Walteros DM; Styczynski A; Garzón F; Quijada H; Bravo E; Chaparro P; Madero J; Acosta-Reyes J; Ledermann J; Arteta Z; Borland E; Burns P; Gonzalez M; Powers AM; Mercado M; Solano A; Sejvar JJ; Ospina ML
    J Neurol Sci; 2017 Oct; 381():272-277. PubMed ID: 28991697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Clinical Case of COVID-19 Vaccine-Associated Guillain-Barré Syndrome.
    Hilts A; Schreiber A; Singh A
    Am J Case Rep; 2022 Aug; 23():e936896. PubMed ID: 35945825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case Report: Post-COVID-19 Vaccine Recurrence of Guillain-Barré Syndrome Following an Antecedent Parainfectious COVID-19-Related GBS.
    Bellucci M; Germano F; Grisanti S; Castellano C; Tazza F; Mobilia EM; Visigalli D; Novi G; Massa F; Rossi S; Durando P; Cabona C; Schenone A; Franciotta D; Benedetti L
    Front Immunol; 2022; 13():894872. PubMed ID: 35924236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases.
    Cea G; Romero C; Aguilar S; Salinas R
    Rev Med Chil; 2021 Dec; 149(12):1812-1816. PubMed ID: 35735350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.